Aptose Biosciences Stock News

SAN DIEGO and TORONTO, Jan. 29, 2020 -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the.

Top Ranked Momentum Stocks to Buy for January 29th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 29th

Investors seeking out high growth for their portfolios will often turn to biotech stocks. The biotechnology industry, which has become densely populated as our understanding of living systems and orga

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 21) Abbott Laboratories (NYSE: ABT ) Apellis Pharmaceu

Investors need to pay close attention to Aptose (APTO) stock based on the movements in the options market lately.

Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.

Aptose Biosciences (APS CN) initiated with Overweight rating at Piper Sandler. Shares up 2% premarket in U.S. (NASDAQ:APTO).BioDelivery Sciences (NASDAQ:BDSI) initiated with Overweight rating and $9

SAN DIEGO and TORONTO, Jan. 07, 2020 -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the.